产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 98% 询价
- +
10mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

251356-45-3

英文名称

SU 16f

别名

(Z)-3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl-6-phenyl)-1H-pyrrol-3-yl)-propionic acid | VEGFR Tyrosine Kinase Inhibitor XXXI | VEGFR2 Kinase Inhibitor XXIX | (E)-3-(2,4-dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)

标准英文名

(Z)-3-(2,4-dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid

分子式

C24H22N2O3

分子量

386.45

精确分子量

386.16

SMILES

O=C(O)CCC1=C(C)NC(/C=C2C(NC3=C\2C=CC(C4=CC=CC=C4)=C3)=O)=C1C

标准SMILES

CC1=C(/C=C2/C3C=CC(=CC=3NC/2=O)C2C=CC=CC=2)NC(C)=C1CCC(O)=O

用途

SU16f is a potent and selective PDGFRβ inhibitor (IC50 = 10 nM), with weaker activity against PDGFRα (IC50 = 140 nM) and PDGFR1 (IC50 = 2.29 μM). It inhibits PDGFRβ activation, thereby blocking the promoting effects of gastric cancer-derived mesenchymal stem cell (GC-MSC) conditioned medium (CM) on gastric cancer cell proliferation and migration. SU16f pretreatment upregulates E-cadherin and downregulates N-cadherin, Vimentin, and α-SMA expression, indicating suppression of epithelial-mesenchymal transition (EMT). Additionally, it modulates apoptosis-related proteins by downregulating p-AKT, Bcl-xL, and Bcl-2, and upregulating Bax in SGC-7901 gastric cancer cells. It is used in vitro to study PDGFR signaling, cancer cell proliferation, migration, EMT, and apoptosis in co-culture systems involving GC-MSCs and gastric cancer cells.

InChIKey

APYYTEJNOZQZNA-MOSHPQCFSA-N

安全信息

SureRoute逆合成路线

1.  251356-45-3 逆合成路线 1

—
—
—
—
ACPFYG702
251356-45-3
来源: SureRoute

2.  251356-45-3 逆合成路线 2

—
—
ACPFYG702
251356-45-3
来源: SureRoute

3.  251356-45-3 逆合成路线 3

—
—
ACPFYG702
251356-45-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手